Redefining ALL classification: Toward detecting high-risk ALL and implementing precision medicine, Curr Hematol Malig Rep, vol.125, pp.158-164, 2014. ,
Pediatricinspired therapy in adults with Philadelphia chromosomenegative acute lymphoblastic leukemia: The GRAALL-2003 study, J Clin Oncol, vol.27, p.2574, 2009. ,
Longterm follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia, Cancer, vol.101, pp.2788-2801, 2004. ,
Rituximab in B-lineage adult acute lymphoblastic leukemia, N Engl J Med, vol.375, pp.1044-1053, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01812704
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia, Blood, vol.130, pp.1832-1844, 2017. ,
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial, Blood, vol.109, pp.3189-3197, 2007. ,
, Oncoge, vol.123, pp.3739-3749, 2014.
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood, vol.125, pp.2486-2496, 2015. ,
Non parametric estimation from incomplete observations, J Am Stat Assoc, vol.53, pp.457-481, 1958. ,
Multinomial regression models based on continuation ratios, Stat Med, vol.7, pp.435-441, 1988. ,
Induction therapy for adults with acute lymphoblastic leukemia: Results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993, all patients: Final results of the International ALL Trial (MRC UKALL XII/ ECOG E2993), vol.106, pp.1827-1833, 2005. ,
Improved lymphoblastic leukemia (ALL), Blood, vol.113, pp.4153-4162, 2009. ,
Significant ALL (GMALL), Blood, vol.122, 2013. ,
Prevention and management of asparaginase/ pegasparaginase-associated toxicities in adults and older adolescents: Recommendations of an expert panel, Leuk Lymphoma, vol.120, pp.526-534, 2015. ,
Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen ,
, Br J Haematol, vol.146, pp.76-85, 2009.
, Clin Oncol, vol.32, pp.905-911, 2016.
, , 2016.
Inotuzuab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients with acute lymphoblastic leukemia (ALL): Interim result of a phase II clinical trial, Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: A GRAALL-2005 study, vol.58, pp.3660-3668, 2016. ,
,
, AP-HP
,
,
,
,
, Angers
,